The acute effect of a single application of cabergoline on endogenous GH levels 
in patients with acromegaly on pegvisomant treatment

Roemmler, J.; Steffin, B.; Gutt, B.; Schneider, H. J.; Sievers, C.; Bidlingmaier, M.; Schopohl, J.

Item

ITEM ACTIONSEXPORT

Add to Basket

Local TagsRelease HistoryDetailsSummary

Released

Journal Article

The acute effect of a single application of cabergoline on endogenous GH levels in patients with acromegaly on pegvisomant treatment

MPS-Authors

/persons/resource/persons80516

Schneider, H. J.
AG Stalla, Günter, Florian Holsboer (Direktor), Max Planck Institute of Psychiatry, Max Planck Society;

/persons/resource/persons80528

Sievers, C.
AG Stalla, Günter, Florian Holsboer (Direktor), Max Planck Institute of Psychiatry, Max Planck Society;

External Resource

No external resources are shared

Fulltext (restricted access)

There are currently no full texts shared for your IP range.

Fulltext (public)

There are no public fulltexts stored in PuRe

Supplementary Material (public)

There is no public supplementary material available

Citation

Roemmler, J., Steffin, B., Gutt, B., Schneider, H. J., Sievers, C., Bidlingmaier, M., et al. (2010). The acute effect of a single application of cabergoline on endogenous GH levels in patients with acromegaly on pegvisomant treatment. Growth Hormone & IGF Research, 20(5), 338-344.

Cite as: https://hdl.handle.net/11858/00-001M-0000-000E-8FC8-C

Abstract

There is no abstract available